3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
14
Phase NA
3
Phase EARLY_PHASE1
3
Phase 3
3
Phase 1/2
2
Phase 1
2
Status
Terminated
2
Completed
1
Sponsor Class
OTHER
2
NETWORK
1
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Breast Neoplasms
13
Carcinoma, Non-Small-Cell Lung
11
Neoplasm Metastasis
7
Brain Neoplasms
7
Rectal Neoplasms
6
Lung Neoplasms
6
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Head and Neck Neoplasms
5
Urinary Bladder Neoplasms
4
Prostatic Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Esophageal Neoplasms
4
Uterine Cervical Neoplasms
3
Pancreatic Neoplasms
3
Melanoma
3
Glioblastoma
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Laryngeal Neoplasms
2
Inflammatory Breast Neoplasms
2
Glioma
2
Central Nervous System Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Adenocarcinoma
2
Vaginal Neoplasms
1
Interventions
Gemcitabine
74
Fluorouracil
31
Oxaliplatin
21
Leucovorin
21
130-nm albumin-bound paclitaxel
17
Capecitabine
14
Irinotecan
12
Albumin-Bound Paclitaxel
10
irinotecan sucrosofate
8
Radiotherapy
6
Taxes
5
Erlotinib Hydrochloride
5
folfirinox
4
rubitecan
3
Surgical Procedures, Operative
3
Specimen Handling
3
Pancreaticojejunostomy
3
Neoadjuvant Therapy
3
Drug Therapy
3
Cisplatin
3
Chemotherapy, Adjuvant
3
ruxolitinib
2
masitinib
2
dehydroftorafur
2
Saline Solution
2
S 1 (combination)
2
Paclitaxel
2
GV1001 peptide
2
Fentanyl
2
Bevacizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Pancreatic Neoplasms
×
Surgical Procedures, Operative
×
Clear all
NCT01900327
2018-05-11
NEOPA
Universitätsklinikum Hamburg-Eppendorf
Phase 3
Terminated
32 enrolled
NCT01419002
2015-07-29
Net-Pac
CHIR-Net
Phase 3
Terminated
5 enrolled
NCT01521702
2015-03-20
NEOPAC
Institut Paoli-Calmettes
Phase 3
Completed
2 enrolled